Jackson Square Partners LLC trimmed its position in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 14.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,627,513 shares of the company's stock after selling 277,982 shares during the quarter. Stevanato Group accounts for approximately 3.8% of Jackson Square Partners LLC's portfolio, making the stock its 4th largest holding. Jackson Square Partners LLC owned about 0.54% of Stevanato Group worth $35,464,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Van Berkom & Associates Inc. purchased a new stake in Stevanato Group in the fourth quarter worth $39,000. PNC Financial Services Group Inc. raised its holdings in shares of Stevanato Group by 1,457.6% in the 4th quarter. PNC Financial Services Group Inc. now owns 5,654 shares of the company's stock valued at $123,000 after acquiring an additional 5,291 shares in the last quarter. US Bancorp DE lifted its position in Stevanato Group by 17.9% during the fourth quarter. US Bancorp DE now owns 8,527 shares of the company's stock valued at $186,000 after purchasing an additional 1,295 shares during the last quarter. Marco Investment Management LLC purchased a new position in Stevanato Group in the fourth quarter worth $203,000. Finally, Hardy Reed LLC raised its holdings in shares of Stevanato Group by 8.2% during the 3rd quarter. Hardy Reed LLC now owns 11,077 shares of the company's stock valued at $222,000 after buying an additional 840 shares in the last quarter.
Stevanato Group Price Performance
Stevanato Group stock traded down €0.07 ($0.08) during mid-day trading on Friday, reaching €20.25 ($22.01). 209,100 shares of the company's stock traded hands, compared to its average volume of 347,647. The stock has a 50 day moving average of €20.90 and a two-hundred day moving average of €20.59. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. Stevanato Group S.p.A. has a 12-month low of €16.56 ($18.00) and a 12-month high of €32.98 ($35.85). The company has a market cap of $6.13 billion, a price-to-earnings ratio of 43.09, a PEG ratio of 7.18 and a beta of 0.60.
Stevanato Group (NYSE:STVN - Get Free Report) last announced its quarterly earnings data on Thursday, March 6th. The company reported €0.20 ($0.22) EPS for the quarter, meeting the consensus estimate of €0.20 ($0.22). The company had revenue of €352.68 million for the quarter, compared to the consensus estimate of €346.26 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. Equities analysts forecast that Stevanato Group S.p.A. will post 0.5 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on the company. Bank of America increased their target price on Stevanato Group from $24.00 to $26.00 and gave the company a "buy" rating in a report on Friday, December 13th. William Blair reaffirmed an "outperform" rating on shares of Stevanato Group in a research report on Friday, March 7th. Wolfe Research began coverage on Stevanato Group in a report on Friday, December 13th. They set an "outperform" rating and a $28.00 target price on the stock. Morgan Stanley reiterated an "equal weight" rating and issued a $23.00 price target (down from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. Finally, UBS Group dropped their target price on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a report on Friday, March 7th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of €25.70 ($27.93).
View Our Latest Stock Analysis on Stevanato Group
Stevanato Group Profile
(
Free Report)
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Recommended Stories
Before you consider Stevanato Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.
While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
